HTT and Alzheimer disease: In addition, analogous to the synthetic peptide for the treatment of AD, the linker that targeted polyQ and two HSC70 binding motifs were combined into a peptide that could be integrated into the repetitive sequence of Htt and guided through CMA degradation, reducing Htt aggregation in the mouse striatum.196